• Merck kicks off Merck Jakarta Diabetes Day in collaboration with Jakarta Government as Part of Its Capacity Advancement Program — CAP in Indonesia after the successful implementation in Africa and India
• Merck joins hands with Jakarta Government to raise awareness about Diabetes early Detection and prevention across the Greater Jakarta.
• Merck Signs MoU with Indonesia University to build future Diabetes healthcare capacity in the country
Merck (http://www.merckgroup.com), a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life-science sectors, rolls out today Merck Jakarta Diabetes Day- MJDD dubbed “Every Day is a Diabetes Day” in collaboration with Jakarta Government in order to encourage people to think diabetes every day. During MJDD Merck will provide in collaboration with Jakarta health office diabetes free screening and education for more than 30,000 community members Across the Greater Jakarta.
HE. Jakarta Governor Ir. Basuki Tjahaya Purnama during the inauguration of the “Merck Jakarta Diabetes Day — MJDD” emphasized “Indonesia is home to the fourth largest population in the world, with many large cities growing at a fast pace. According to World Atlas, Greater Jakarta alone is the second largest city in the world. This fact means that diabetes prevalence will increase significantly, if it is not taken as a matter of urgency.
The expanding diabetes epidemic has devastating effects on the development of healthcare systems and economies in emerging countries, both in terms of direct health care costs and loss of working time and complications and disability management, therefore, Jakarta Government is supporting Private Public Partnership-PPP with reputable companies like Merck to contribute to raising awareness about diabetes so that people are encouraged to think Diabetes everyday and not only one day a year “
During “Merck Jakarta Diabetes Day”, Dr Frank Stangenberg Haverkamp, The Chairman of Excusive Board and Family Board of E. Merck KG stated “We are pleased to engage with the Government of Jakarta to improve access to better Diabetes Care as part of our commitment to the social and economic development of Indonesia. Supporting the Diabetes education and community awareness will contribute significantly to improving early detection and prevention of the disease across Greater Jakarta and Indonesia”.
“Like many countries undergoing rapid socio-economic transition, Indonesia is struggling with the fast-growing burden of diabetes. Facing this challenge compels stakeholders to align their vision in a way that leads to better awareness and improves access to innovative healthcare solutions,” Vice PresidentHead of Global BusinessSocial Responsibility and Market Development at Merck Serono Rasha Kelej emphasized
Merck will roll out “Merck Diabetes Day” across the globe to raise public awareness about Diabetes early detection and prevention, aiming to encourage people to change their life style to fight diabetes everyday in order to reverse this worrying trend of a steep increase in Diabetes by preventing or at least delaying the development of diabetes in the low and middle income countries as part of Merck Corporate Social Responsibility Agenda.
On the same day, Merck has signed MOU with Faculty of Pharmacy, University of Indonesia to build future Diabetes healthcare capacity in Indonesia as part of Merck Capacity Advancement Program..
The fast growing burden of Diabetes in Indonesia:
According to the International Diabetes Federation (IDF), there were more 9 million cases of diabetes in Indonesia in 2014 with 53% are undiagnosed. Diabetes Prevalence is 5.8% and reaches to up to 12% in some urban areas where diabetes is the second cause of death. Type 2-diabetes is a growing epidemic in the Asia-Pacific countries, mainly due to the adoption of a western life-style and the increasing occurrence of obesity.
Your contact: Tel: Gadis Parengkuan e-mail: [email protected]
About the Merck Capacity Advancement Program (CAP)
Merck CAP is a 5 year program aiming to expand the professional capacity in developing countries in the areas of research and development, advocacy building, supply-chain integrity and efficiency, pharmacovigilance, medical education, and community awareness.
As part of the CAP, by end of 2015, more than 7,000 medical students in partnership with African universities such as University of Nairobi, Makerere University, Namibia University and University of Ghana, in addition to Asian universities such as Maharashtra university, India and University of Indonesia will benefit from European-accredited clinical chronic diseases management training, which is seeking to equip them with skills to better manage and prevent these diseases.
Merck has partnered with Nairobi Government, Kenya and Uganda ministries of Health and University of Nairobi to provide free diabetes screening and Cancer awareness and prevention education for more than 5000 community members across the two countries, in April and June 2015.
Merck has provided free diabetes screening for more than 40,000 community members across Maharashtra state in India, in partnership with Maharashtra Ministry of Health and social welfare and Maharashtra University.
Merck is planning to reach more than 200,000 community members and more than 19,000 students by the end of 2018 expanding to more African, Asian, Latin American and Middle Eastern countries with special focus on non—communicable diseases such as diabetes, cancer and fertility management. The program will also kick off initiatives on building research capacity and improving supply chain in order to improve patient safety in Africa.
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
Merck is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company comprises six businesses — Merck Serono, Consumer Health, Allergopharma, Biosimilars, Merck Millipore and Performance Materials — and generated sales of € 11.3 billion in 2014. Around 39,000 Merck employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company — since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company operates under EMD Serono, EMD Millipore and EMD Performance Materials.